{"symbol": "RTTR", "companyName": "Ritter Pharmaceuticals Inc.", "exchange": "NASDAQ Capital Market", "industry": "Biotechnology", "website": "http://www.ritterpharmaceuticals.com", "description": "Ritter Pharmaceuticals Inc develops novel therapeutic products that modulate the gut microbiome to treat gastrointestinal diseases.", "CEO": "Andrew J. Ritter", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}